Impact of SGLT2 Inhibitors on Cardiac Rehabilitation Outcomes
Received Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Abstract
Cardiac rehabilitation (CR) is a comprehensive program designed to improve cardiovascular health and quality of life in patients with heart disease. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally developed for managing diabetes, have recently gained attention for their potential cardiovascular benefits. This article explores the impact of SGLT2 inhibitors on cardiac rehabilitation outcomes, highlighting their effects on exercise tolerance, weight management, and overall cardiovascular risk.
Citation: James S (2024) Impact of SGLT2 Inhibitors on Cardiac Rehabilitation Outcomes. J Card Pulm Rehabi 8: 276.
Copyright: © 2024 James S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 76
- [From(publication date): 0-0 - Dec 04, 2024]
- Breakdown by view type
- HTML page views: 49
- PDF downloads: 27
